ZURICH/BERLIN, Jan 25 (Reuters) - The Swiss blue-chip SMI was seen opening 0.2 percent higher at 8,954 points on Friday, according to premarket indications by bank Julius Baer .
The watchmaker will ask shareholders to reduce the group's equity capital by cancelling stock that the company has repurchased, it said.
The drugmaker's U.S. unit Genentech named Alexander Hardy as its CEO, to replace Bill Anderson, who was recently named the head of the Swiss company's drugs division.
The company said its 2018 net income fell by nearly 8 percent as higher financing costs and foreign currency losses hit the fragrance and flavourings maker.
For more news, click on
* Ascom Holding said Jeannine Pilloud Nominated As New Chairperson Of The Board Of Directors
* SFS reported full-year revenue growth of 6.5 percent, with operating income of 243 mln Sfr.
* Compagnie Financiere Tradition reported full-year revenue growth of 9.5 percent at constant currencies.
* Conzzeta said it was disposing of its glass processing segment. * HBM Healthcare Investments reported a 9-month profit of 81 million francs.
SWATCH - Credit Suisse cuts to "neutral" from "outperform", cuts price target to 340 Sfr vs 510 Sfr
SGS - Credit Suisse cuts to "neutral" from "outperform", cuts price target to 2,400 Sfr vs 2,700 Sfr
No major economic data scheduled. (Reporting by Zurich newsroom and Berlin Speed Desk)